IDEAYA Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	23.39	50.93	27.94	19.54	0	0	0
Revenue Growth (YoY)	-54.08%	82.28%	43.01%	-	-	-	-
Gross Profit	23.39	50.93	27.94	19.54	0	0	0
Selling, General & Admin	28.31	23.9	20.05	15.18	9.95	4.67	2.05
Research & Development	129.51	89.54	58.16	39.7	34.32	31.75	12.38
Operating Expenses	157.81	113.43	78.21	54.88	44.27	36.42	14.44
Operating Income	-134.43	-62.5	-50.27	-35.34	-44.27	-36.42	-14.44
Other Expense / Income	-21.47	-3.85	-0.51	-0.85	-2.3	-2.07	-2.58
Pretax Income	-112.96	-58.66	-49.76	-34.5	-41.98	-34.35	-11.86
Net Income	-112.96	-58.66	-49.76	-34.5	-41.98	-34.35	-11.86
Shares Outstanding (Basic)	58	41	35	25	12	1	1
Shares Outstanding (Diluted)	58	41	35	25	12	1	1
Shares Change	38.79%	17.57%	42.60%	97.82%	1206.87%	37.52%	-
EPS (Basic)	-1.96	-1.42	-1.41	-1.40	-3.36	-35.92	-17.06
EPS (Diluted)	-1.96	-1.42	-1.41	-1.40	-3.36	-35.92	-17.06
Free Cash Flow	-117.59	-90.62	-58.42	54.97	-40.67	-29.33	-13.98
Free Cash Flow Per Share	-2.04	-2.19	-1.66	2.22	-3.25	-30.67	-20.11
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-574.85%	-122.72%	-179.91%	-180.90%	-	-	-
Profit Margin	-483.05%	-115.17%	-178.10%	-176.55%	-	-	-
Free Cash Flow Margin	-502.85%	-177.92%	-209.09%	281.35%	-	-	-
EBITDA	-108.95	-55.14	-46.73	-33.11	-40.73	-33.46	-11.47
EBITDA Margin	-465.91%	-108.26%	-167.25%	-169.49%	-	-	-
Depreciation & Amortization	4.01	3.52	3.03	1.38	1.25	0.89	0.39
EBIT	-112.96	-58.66	-49.76	-34.5	-41.98	-34.35	-11.86
EBIT Margin	-483.05%	-115.17%	-178.10%	-176.55%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).